Biotech is ‘uncrowded’

he Nasdaq Biotech Index has been ‘the same price’ for the past 20 months.

Specifically, it has traded within 6% either side of today’s closing price over that time.

While it has spent some time ‘digesting’, its price action is now becoming quite constructive.

Also, it’s hardly a crowded theme.

September 16, 2023

by Rob Zdravevski

rob@karriasset.com.au